Svmuu reported that Caixin published an article titled "SpaceX's $1.75 Trillion IPO Approaches: Who Can Buy and Is It Worth It?", which points out: Wall Street has never encountered a listed company with such a massive IPO scale while simultaneously having such a complex relationship with the U.S. government. Nasdaq has previously passed a new "Fast Entry" rule, allowing newly listed companies with a market capitalization ranking among the top 40 of the Nasdaq 100 Index to be quickly included in the Nasdaq 100 within 15 trading days after listing. This rule will officially take effect on May 1, 2026, and is also considered to be designed for the upcoming SpaceX IPO, while potentially paving the way for the listings of OpenAI and Anthropic, which may occur in 2026 or 2027.
Assuming SpaceX lists with a $1.75 trillion valuation and a free float ratio of 25% to 30%, the free float market cap on the first day of the IPO would be approximately between $440 billion and $530 billion. Based on the weight calculation of the Nasdaq 100, SpaceX would directly enter the top ten weighted stocks. According to market sources, the S&P 500 is also evaluating some form of "fast inclusion" plan, though details have not yet been disclosed. (Caixin)
Caixin: SpaceX IPO First Day Free Float Market Cap Could Be Between $440 Billion and $530 Billion
Source:Odaily · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
Billionaire investor Chase Coleman’s Tiger Global fund disclosed in its latest 13F filing that its top five growth stocks are all focused on AI infrastructure, including TSMC, NVIDIA, Amazon, Meta, and Google.
-
2
Liquidity Crunch in Cryptocurrency Mining: Causes and Analysis of the Current Situation in 2026
-
3
Analysis of CRYSTAL’s Value and Investment Potential: An Examination of Multiple Projects and Risk Assessment
-
4
Will the BEAM token go to zero? Could it rise to $1,000? An in-depth analysis of the Beam network and its market prospects
-
5
The analysis points out that Iran’s overlapping centers of power complicate efforts to end the war with the United States, and that the Revolutionary Guards possess significant operational autonomy.
-
6
Israeli West Bank Settler Tells BBC Attacks on Palestinians Are Justified as Revenge, Equating One Jewish Life to "10 Million" Palestinians
-
7
ETH2X-FLI-P: An Analysis of the 2x Leveraged Ethereum Index Token on Polygon
-
8
WASM: An In-Depth Look at WebAssembly Technology and a Guide to Trading Related Tokens ZKWASM and WASM AI
-
9
What Is CVP? An In-Depth Analysis of the PowerPool Ecosystem and the Investment Value of Its Token, CVP
-
10
Analysis: The State Street Healthcare ETF (XLV) has an expense ratio of 0.08% and a diversified portfolio, while the Invesco Biotechnology ETF (PBE) has an expense ratio of 0.58% and focuses on small-cap stocks; PBE is up 10.2% year-to-date, outperforming XLV.
Markets Today
Recommended Reading








